Researchers from Brown University touted the efficacy of tumor ablation in treating small-cell lung cancer, publishing their results in the Journal of Vascular and Interventional Radiology. 

Preclinical researchers in Denmark have combined MRI and CT to create a new way to image tracer distribution in tumors at extremely high resolution in mice. Their hope is to translate the technique to map the branching of tumor blood vessels in humans, such that tumor-busting drugs could be carefully observed in action. 

Comic actor Ben Stiller’s reveal on his victory over prostate cancer has drawn heavy coverage well beyond the celebrity press. Much of the reporting has rightly noted the big-heartedness of his public service but, curiously, hasn’t questioned his assertion that it was specifically PSA testing that saved his life. 

MRI-guided prostate interventions appear to have a bright future combining with the latest and greatest radiation therapy techniques to make prostatectomy and no therapy at all the least attractive options for most men with low-to-intermediate-grade prostate cancer. 

BOSTON—Compared with conventional radiation therapy (RT), larger-dose RT delivered over a shorter period—called hypofractionated RT—has previously proven just as efficacious for treating low-risk, early-stage prostate cancer. Now researchers have further shown that, despite the increased doses, hypofractionated treatments do no clinically significant harm to these patients’ quality of life (QOL). 

BOSTON—Stereotactic body radiation therapy (SBRC) has beaten the pants off conventional radiation therapy in the Veterans Health Administration, significantly boosting both overall and lung cancer-specific survival in thousands of patients with stage I non-small cell lung cancer (NSCLC) in the first decade of the 21st century. 

BOSTON—If given the chance to choose between two recurrence-busting radiotherapy methods, many patients who have had a metastatic tumor resected from their brain would likely choose finely targeted stereotactic radiosurgery (SRS) applied only to the surgical bed of the resected lesion over radiation therapy applied to the entire brain. 

Helping radiation oncologists learn from their own medical errors, adopt standardized best practices and participate more prominently in the Obama administration’s “cancer moonshot”: Those three areas of activity currently top the priority list of the American Society for Radiation Oncology (ASTRO).